Myanmar Import Data for Antisera and Blood Fractions Under HS Code 300212
HS Code 300212 is officially defined as Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products : Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera and other blood fractions in Myanmar. Explore Myanmar import shipment records for Antisera and Blood Fractions classified under HS Code 300212.
Latest Myanmar Import Trade Records For Antisera and Blood Fractions Under HS Code 300212
As of 2026-07-15, companies recorded in Myanmar import shipments of Antisera and Blood Fractions (HS Code 300212) include Vins Bioproducts Limited, Grand Medicore Company limited and GSM DIAGNOSTIC CO., LTD, as declared on bill of lading trade records. These shipments originate from INDIA. In 2024, Myanmar's total import value for Antisera and Blood Fractions was US$ 174,282. Full shipment records include fields such as exporter, importer, country of origin, destination country, trade value, weight, quantity, and ports of loading and discharge.
Subscribe Now to run unlimited searches and unlock full shipment records, trade partners and trade metrics for Antisera and Blood Fractions under HS Code 300212.
1-10 of 8,200M+ Bill of Lading database covers import export Trade records updated till 2026-07-15
Access Full & Detailed Trade Data for HS Code 300212
Reveal full shipment records, buyers, suppliers and trade metrics for Antisera and Blood Fractions, and run unlimited searches across TradeInt global trade database.
Top Import Products Related to HS Code 300212 (Antisera and Blood Fractions) in Myanmar
Based on Myanmar import trade data, top import products related to HS Code 300212 in Myanmar are:
Aggregated Myanmar import data for 2024.